{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02788747","recordId":"NCT02788747","peptideSlug":"elamipretide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02788747-elamipretide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02788747.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02788747.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-05-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"elamipretide","submittedDate":"2016-05-27","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"5484c12f37bcc52f5e0a2d93d0e402ec488d52c8fb0f0372701d586247c6acf4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"elamipretide","submittedDate":"2016-06-08","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"f141e7c3a5599dc4423877da3e98ed86cedb6ead15b4fa30fd914158ebc252d3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-06-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"elamipretide","submittedDate":"2016-06-15","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"b937dab055ba1b5f8a6922d7a1a6a51cdc61c6804d007d772759a7a6376ef0e9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-03-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"elamipretide","submittedDate":"2017-03-13","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"315451d62bedc7be6f808f640d13acd03ca8d8a63d88fc0226be269f1d4e2790","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"elamipretide","submittedDate":"2017-05-03","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"db608b9f72f79f668004b8c17df3e8e81d1a9a9b0f277bc7100e406208fc9cdd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-09-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"elamipretide","submittedDate":"2017-09-06","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"61fbe63a440bb1da4b8b871f301a78451c612efffcca130633cfd9455ce2a665","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2018-02-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"elamipretide","submittedDate":"2018-02-22","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"54bee533bd5983fba3ff7feb4e170fe266a58c36f7dc8914160f5d11a566ce99","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2019-07-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"elamipretide","submittedDate":"2019-07-17","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"84a6a12569742fc56bebce5dc68bf0a20df48df51634fdff9e7c07ea60135118","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2019-07-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"elamipretide","submittedDate":"2019-07-17","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"a169d44cc3bbb1e82e0357418e7054a9b454d120c594392ff9a94ba079b6cdc2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Contacts/Locations","Document Section","Eligibility","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2020-04-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"elamipretide","submittedDate":"2020-04-06","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"8bbc2537d611734e0017b8c7a5ccd9c515e4e07349bf49a6a0b78963dfd65fe6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Limitations and Caveats","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2020-05-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"elamipretide","submittedDate":"2020-05-05","publishedAt":"2026-08-23","recordId":"NCT02788747","recordSha256":"309a1288fae5b14239f123bf8f4269cc4b4c90d6065652bb8a97a5f8a11391a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02788747?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"7a581d31f0106d969abf6b6e8a40f4b7d739738a7069acad49d6ee4eb4a09e89"}}
